Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 7, 2002, Pages 349-357

  Lage, Hermann ^a   Dietel, Manfred ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Antineoplastic agents; DNA topoisomerase II; Drug resistance; EPP85 181; Pancreatic carcinoma

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; DAUNORUBICIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); GLYCOPROTEIN P; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CATALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; CROSS RESISTANCE; DRUG ACCUMULATION; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBUNIT; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL SURVIVAL; DAUNORUBICIN; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, NEOPLASM; HUMANS; KINETICS; MITOXANTRONE; P-GLYCOPROTEIN; PANCREATIC NEOPLASMS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036321081     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0349-y     Document Type: Article

References (34)

1. A family of drug transporters: The multidrug resistance-associated proteins
2. Patterns of DNA methylation and gene expression in human tumor cell lines
3. Single-strand conformational polymorphism analysis of the M(r) 170,000 isoenzyme of DNA topoisomerase II in human tumor cells
4. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines
5. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
6. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257
7. Multidrug resistance in cancer: Role of ATP-dependent transporters
8. Mitoxantrone resistance in HL-60 leukemia cells: Reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform
9. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line
10. Cloning and characterization of the 5′-flanking region of the human topoisomerase α gene
11. Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localization of the gene to chromosome 3p24
12. Reversal of the malignant phenotype by an anti-ras ribozyme
13. Characterization of an etoposide-resistant human ovarian cancer cell line
14. Simple microassay of protein with membrane filter
15. Effect of the breast cancer resistance protein on atypical multidrug resistance
16. Modulation of DNA Topoisomerase II activity and expression in melanoma cells with acquired drug resistance
17. Thermosensitivity of multidrug-resistant human gastric and pancreatic carcinoma cells
18. Enhanced expression of human ABC-transporter TAP is associated with cellular resistance to mitoxantrone
19. DNA methylation, nuclear structure, gene expression and cancer
20. DNA topoisomerase poisons as antitumor drugs
21. Cleavage of DNA by mammalian DNA topoisomerase II
22. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines
23. Decatenation of kinetoplast DNA by topoisomerase II
24. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells
25. Mechanism of antitumor drug action: Poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinyl-amino)-methanesulfon-m-aniside
26. Mechanism of action of topoisomerase II-targeted antineoplastic drugs
27. Atypical multidrug resistance: Breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines
28. Decreased levels of topoisomerase IIα in human renal cell carcinoma lines resistant to etoposide
29. New colorimetric cytotoxicity assay for anticancer-drug screening
30. DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: Implications for the mechanisms of action
31. Reduced activity of topoisomerase II in an adriamycin-resistant human stomach-adenocarcinoma cell line
32. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells
33. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22
34. Proliferation and cell cycle-dependent differences in expression of the 170 kilodalton and the 180 kilodalton forms of DNA topoisomerase II in NIH-3T3 cells